APPLICATION
ANDA200160
TYPE
ANDA
ORIGINAL APPROVAL
2014-04-03
LATEST ACTION
2026-07-20
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
MOXIFLOXACIN HYDROCHLORIDEDiscontinued
MOXIFLOXACIN HYDROCHLORIDE EQ 400MG BASE · TABLET · ORAL
Approval history
2026-07-20Labeling · Supplement 8 · standardAP
2020-11-02Labeling · Supplement 4 · standardAP
2020-11-02Labeling · Supplement 2 · standardAP
2020-11-02Labeling · Supplement 5 · standardAP
2020-11-02Labeling · Supplement 3 · standardAP
2020-11-02Labeling · Supplement 1 · standardAP
2020-11-02Labeling · Supplement 6 · standardAP
2014-04-03UNKNOWN · OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.